VarCov Co’s Organon & Co OGN Stock Holding History

VarCov Co’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-87,302	Closed	-$523K	–	498
2026 Q1	$523K	Sell	87,302 -100,174	-53%	-$754K	0.2%	197
2025 Q4	$1.34M	Buy	+187,476	New	+$1.48M	0.53%	32

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

VarCov Co's OGN Position: Q2 2026 in Review

VarCov Co sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 87,302 shares — an estimated $523K sold.

VarCov Co first reported a position in OGN in Q4 2025 and held it in 2 quarters. The position peaked at $1.34M in Q4 2025. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

VarCov Co reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
VarCov Co sold 87,302 Organon & Co shares in Q2 2026, an estimated $523K.
VarCov Co first reported a position in Organon & Co in Q4 2025 and held it in 2 quarters.
VarCov Co's Organon & Co position peaked at $1.34M in Q4 2025.
627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.